[Totally implantable venous access sites. Results of a series of 101 cases].
The authors report their results of the use of 101 totally implanted venous access systems for chemotherapy in 92 patients. They stress the high incidence (19.8%) of complications: thrombosis 6.8% and 6.9% linked to the material. The correct complication rate must be decreased by strict attention paid to the surgical procedure, use and greater education of the nursing staff. The value of this material is to give greater comfort to patients and to assess its widespread use for intensive long-term chemotherapy.
Azencot
A
A
Service de Chirurgie Générale B, Centre Hospitalier Général et Universitaire, Limoges.
Valleix
D
D
Descottes
B
B
Olivier
J P
JP
D000328:Adult; D000368:Aged; D000970:Antineoplastic Agents / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000188:drug therapy; D004067:Digestive System Neoplasms / Q000188:drug therapy; D005260:Female; D006801:Humans; D015918:Infusion Pumps, Implantable; D008228:Lymphoma, Non-Hodgkin / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D010051:Ovarian Neoplasms / Q000188:drug therapy; D011030:Pneumothorax / Q000209:etiology*; D018805:Sepsis / Q000209:etiology*; D013924:Thrombophlebitis / Q000209:etiology*; D013927:Thrombosis / Q000209:etiology*
D000970:Antineoplastic Agents
Sites d'accès veineux totalement implantables. Résultats d'une série de 101 cas.